153 related articles for article (PubMed ID: 6761857)
1. Uremic middle molecules. Accumulation, renal excretion and elimination by extra-corporeal treatment.
Asaba H
Scand J Urol Nephrol Suppl; 1982; 67():1-65. PubMed ID: 6761857
[No Abstract] [Full Text] [Related]
2. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
Lustenberger N; Schindhelm K; Nordmeyer C; Schurek HJ; Stolte H
Artif Organs; 1981; 4 Suppl():110-4. PubMed ID: 7295076
[TBL] [Abstract][Full Text] [Related]
3. A bench to bedside view of uremic toxins.
Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
[TBL] [Abstract][Full Text] [Related]
4. [Chronic kidney failure: problems of pathogenesis and treatment].
Ermolenko VM
Ter Arkh; 1982; 54(7):114-8. PubMed ID: 6753210
[No Abstract] [Full Text] [Related]
5. Uremic toxins: a new focus on an old subject.
Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
[TBL] [Abstract][Full Text] [Related]
6. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
Nesse AB; Arrizurieta de Muchnik E
Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
[No Abstract] [Full Text] [Related]
7. The anglerfish and uremic toxins.
Lowenstein J
FASEB J; 2011 Jun; 25(6):1781-5. PubMed ID: 21622695
[No Abstract] [Full Text] [Related]
8. [Metabolic anomaly and uremic toxins in chronic renal insufficiency].
Ueda Y
Nihon Rinsho; 1974 Mar; 32(3):446-8. PubMed ID: 4859022
[No Abstract] [Full Text] [Related]
9. Renal handling of uremic middle molecules. a study with the isolated perfused rat kidney.
Schindhelm K; Schlatter E; Schurek HJ; Stolte H
Nephron; 1982; 30(2):166-72. PubMed ID: 7099324
[TBL] [Abstract][Full Text] [Related]
10. [The secretory performance of eccrine sweat glands from the nephrologic viewpoint--II: Middle molecules].
Koban F; Adler D; Gens C; Gehrisch S; Rose W; Hornak H; Heinrich HG
Z Gesamte Inn Med; 1989 May; 44(9):257-60. PubMed ID: 2741521
[TBL] [Abstract][Full Text] [Related]
11. Influence of factors in the digestive tract on the progression of chronic renal failure.
Takahashi S; Okada K; Shimamura T
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):1-11. PubMed ID: 8336393
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal strategies for the removal of middle molecules.
Winchester JF; Audia PF
Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
[TBL] [Abstract][Full Text] [Related]
13. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
Kon'kova TA; Chudnovskaia MV; Golovanov SA
Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
[TBL] [Abstract][Full Text] [Related]
14. [Transfusiologic technics for the prevention and treatment of acute renal failure in the DIC syndrome in children].
Levanovich VV; Gnipov AP; Aleĭnikov VG; Burushkina TN
Vestn Khir Im I I Grek; 1984 Feb; 132(2):103-6. PubMed ID: 6719703
[TBL] [Abstract][Full Text] [Related]
15. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
16. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
[TBL] [Abstract][Full Text] [Related]
17. [Determination of substances of middle molecular mass in the body fluids of patients treated with intermittent peritoneal dialysis].
Dukanović L; Petrović J
Lijec Vjesn; 1982; 104(11-12):527-9. PubMed ID: 7187480
[No Abstract] [Full Text] [Related]
18. [The factors that determine the manifestation of uremic poisoning during the development of chronic kidney failure].
Rumiantsev ASh; Panina IIu; Kozlov VV; Lukichev BG; Tsiura VI; Kaznacheeva IG; Abdiadilova LV
Ter Arkh; 1991; 63(6):71-4. PubMed ID: 1948753
[TBL] [Abstract][Full Text] [Related]
19. [Hemosorption as a treatment method for uremic complications].
Pilotovich VS; Ostapenko VA; Shilaĭ LM; Kirkovskiĭ VV; Nikolaĭchik VV
Klin Med (Mosk); 1982 Apr; 60(4):77-80. PubMed ID: 7098397
[No Abstract] [Full Text] [Related]
20. [Middle molecules--a marker of endogenous intoxication (a review of the literature)].
Parfenkova GA; Cherniad'eva IF; Sitina VK
Vrach Delo; 1987 Apr; (4):72-7. PubMed ID: 3303687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
